Rebecca Shatsky: One of our MOST innovative I-SPY 2 trial arms ever got accepted at ASCO2024 as an oral presentation
Rebecca Shatsky shared a post on X:
“Very happy to announce that 1 of our MOST innovative I-SPY 2 trial arms ever got accepted at ASCO2024 as an oral presentation. I also happen to be f1st author on this 1 . If you want to talk PERSONALIZED curative intent breast cancer therapy come hear me speak on June 3rd!
Source: Rebecca Shatsky/X
Rebecca A. Shatsky is an Associate Professor of Medicine and a board-certified medical oncologist at the University of California, San Diego. She specializes in treating breast cancer and is part of UC San Diego Health’s Precision Immunotherapy Clinic. Dr. Shatsky is a member of the NCCN guideline panel for Genetic/High-Risk Assessment of Breast, Ovarian, and Pancreatic Cancer and the panel for the treatment of Cancer-Associated Pain. Dr. Shatsky is a well known social media influencer.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023